158 (PB038) - RVU120, a small molecule inhibitor of CDK8/19 kinases, enhances rituximab-driven NK cells-mediated cytotoxicity both in vitro and in vivo

Autor: Białopiotrowicz-Data, E., Dziedzic, K., Podkalicka, P., Grycuk, K., Gołas, A., Dolata, I., Chmielewski, S., Pilch, Z., Nowis, D., Juszczyński, P., Rzymski, T.
Zdroj: In European Journal of Cancer October 2022 174 Supplement 1:S56-S57
Databáze: ScienceDirect